Vivos Therapeutics (VVOS)
(Delayed Data from NSDQ)
$2.10 USD
-0.07 (-3.23%)
Updated Aug 2, 2024 03:59 PM ET
After-Market: $2.05 -0.05 (-2.38%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
VVOS 2.10 -0.07(-3.23%)
Will VVOS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VVOS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VVOS
Here Is Why Bargain Hunters Would Love Fast-paced Mover Vivos Therapeutics, Inc. (VVOS)
Here's Why Vivos Therapeutics, Inc. (VVOS) Could be Great Choice for a Bottom Fisher
VVOS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Tops Revenue Estimates
Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates
Other News for VVOS
Vivos Therapeutics files to sell 169,498 shares of common stock for holders
Vivos gains as pilot program validates new market model
Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model
Vivos announces results from 7-month pilot of new distribution model
Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance